75 related articles for article (PubMed ID: 20232708)
1. [Prostate specific antigen--PSA and histopathological findings of endometrium in women with fibrocystic breast disease].
Radowicki S; Kunicki M
Ginekol Pol; 2010 Feb; 81(2):111-4. PubMed ID: 20232708
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen in the serum of women with benign breast disease.
Radowicki S; Kunicki M; Bandurska-Stankiewicz E
Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):212-6. PubMed ID: 17850950
[TBL] [Abstract][Full Text] [Related]
3. Prostate specific antigen in women with menstrual disturbances and fibrocystic mastopathy.
Radowicki S; Kunicki M
J Endocrinol Invest; 2009 Nov; 32(10):821-4. PubMed ID: 19602918
[TBL] [Abstract][Full Text] [Related]
4. Serum total and free prostate-specific antigen for breast cancer diagnosis in women.
Black MH; Giai M; Ponzone R; Sismondi P; Yu H; Diamandis EP
Clin Cancer Res; 2000 Feb; 6(2):467-73. PubMed ID: 10690525
[TBL] [Abstract][Full Text] [Related]
5. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.
Romppanen J; Keskikuru R; Kataja V; Eskelinen M; Kosma VM; Savolainen K; Uusitupa M; Mononen I
Br J Cancer; 1999 Mar; 79(9-10):1583-7. PubMed ID: 10188910
[TBL] [Abstract][Full Text] [Related]
6. [Prostate specific antigen in women].
Michał K; Stanisław R
Ginekol Pol; 2010 Sep; 81(9):704-7. PubMed ID: 20973208
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen detection by ultrasensitive assay in samples from women.
Filella X; Molina R; Alcover J; Menéndez V; Giménez N; Jo J; Carretero P; Ballesta AM
Prostate; 1996 Nov; 29(5):311-6. PubMed ID: 8899004
[TBL] [Abstract][Full Text] [Related]
8. Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease.
Borchert GH; Yu H; Tomlinson G; Giai M; Roagna R; Ponzone R; Sgro L; Diamandis EP
J Clin Lab Anal; 1999; 13(2):75-81. PubMed ID: 10102136
[TBL] [Abstract][Full Text] [Related]
9. [Prostate specfic antigen in serum of healthy women].
Radowicki S; Kunicki M; Wierzba W
Ginekol Pol; 2006 Dec; 77(12):922-5. PubMed ID: 17373117
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of endometrial histologic morphology in patients with polycystic ovary syndrome].
Rudnicka E; Wierzba W; Radowicki S
Ginekol Pol; 2009 Feb; 80(2):103-6. PubMed ID: 19338206
[TBL] [Abstract][Full Text] [Related]
11. Prostate specific antigen and mastopathy.
Wiwanitkit V
J Endocrinol Invest; 2010 Jun; 33(6):437. PubMed ID: 20631497
[No Abstract] [Full Text] [Related]
12. Changes of PSA concentrations in serum and saliva of healthy women during the menstrual cycle.
Aksoy H; Akçay F; Umudum Z; Yildirim AK; Memisogullari R
Ann Clin Lab Sci; 2002; 32(1):31-6. PubMed ID: 11848615
[TBL] [Abstract][Full Text] [Related]
13. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
Bangma CH; Kranse R; Blijenberg BG; Schröder FH
Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
[TBL] [Abstract][Full Text] [Related]
14. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
[TBL] [Abstract][Full Text] [Related]
15. The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.
Bangma CH; Kranse R; Blijenberg BG; Schröder FH
Urology; 1995 Dec; 46(6):773-8. PubMed ID: 7502414
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen in serum during the menstrual cycle.
Zarghami N; Grass L; Sauter ER; Diamandis EP
Clin Chem; 1997 Oct; 43(10):1862-7. PubMed ID: 9342005
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
Becker C; Piironen T; Pettersson K; Björk T; Wojno KJ; Oesterling JE; Lilja H
J Urol; 2000 Jan; 163(1):311-6. PubMed ID: 10604382
[TBL] [Abstract][Full Text] [Related]
18. Super-sensitive prostate-specific antigen (PSA) in serum of women with benign breast disease or breast cancer.
Hautmann S; Huland E; Grupp C; Haese A; Huland H
Anticancer Res; 2000; 20(3B):2151-4. PubMed ID: 10928169
[TBL] [Abstract][Full Text] [Related]
19. Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia.
Paus E; Nilsson O; Børmer OP; Fosså SD; Otnes B; Skovlund E
J Urol; 1998 May; 159(5):1599-605. PubMed ID: 9554362
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk.
Sauter ER; Daly M; Linahan K; Ehya H; Engstrom PF; Bonney G; Ross EA; Yu H; Diamandis E
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):967-70. PubMed ID: 8959318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
